Finfeed Archived Apr 08, 2021
Creso Pharma's (ASX: CPH) wholly-owned Canadian subsidiary, Mernova Medicinal has secured new purchase orders valued at C$145,192
Finfeed Archived Feb 03, 2021
Investors who took a stake in Creso Pharma (ASX:CPH) three months ago are now looking at a near ten-bagger, with more upside to come.
Get expert stock analysis direct in your inbox
Join OurMailing List
